Guerra T, Iaffaldano P
Int J Mol Sci. 2025; 26(3).
PMID: 39940654
PMC: 11817336.
DOI: 10.3390/ijms26030884.
Liu X, Lv W, Huang D, Cui H
BMC Cancer. 2025; 25(1):87.
PMID: 39815237
PMC: 11734324.
DOI: 10.1186/s12885-025-13484-7.
Pachner A, Pike S, Smith A, Gilli F
Biomolecules. 2025; 14(12.
PMID: 39766248
PMC: 11673926.
DOI: 10.3390/biom14121541.
Simic M, Watchmaker P, Gupta S, Wang Y, Sagan S, Duecker J
Science. 2024; 386(6726):eadl4237.
PMID: 39636984
PMC: 11900893.
DOI: 10.1126/science.adl4237.
Jiang X, Zhang H, Liu Y, Sun B, Mu G
Front Immunol. 2024; 15:1442694.
PMID: 39611149
PMC: 11602428.
DOI: 10.3389/fimmu.2024.1442694.
Cellular and Immunological Analysis of 2D2/Th Hybrid Mice Prone to Experimental Autoimmune Encephalomyelitis in Comparison with 2D2 and Th Lines.
Aulova K, Urusov A, Chernyak A, Toporkova L, Chicherina G, Buneva V
Int J Mol Sci. 2024; 25(18).
PMID: 39337388
PMC: 11432411.
DOI: 10.3390/ijms25189900.
Combination of tumor antigen drainage and immune activation to promote a cancer-immunity cycle against glioblastoma.
Xu H, Zhao X, Luo J
Cell Mol Life Sci. 2024; 81(1):275.
PMID: 38907858
PMC: 11335198.
DOI: 10.1007/s00018-024-05300-5.
CNS Resident Innate Immune Cells: Guardians of CNS Homeostasis.
Muzio L, Perego J
Int J Mol Sci. 2024; 25(9).
PMID: 38732082
PMC: 11084235.
DOI: 10.3390/ijms25094865.
Tertiary lymphoid structures in autoimmune diseases.
Dong Y, Wang T, Wu H
Front Immunol. 2024; 14:1322035.
PMID: 38259436
PMC: 10800951.
DOI: 10.3389/fimmu.2023.1322035.
Single-Cell Profiling Indicates a Proinflammatory Role of Meningeal Ectopic Lymphoid Tissue in Experimental Autoimmune Encephalomyelitis.
Diddens J, Lepennetier G, Friedrich V, Schmidt M, Brand R, Georgieva T
Neurol Neuroimmunol Neuroinflamm. 2023; 11(1):e200185.
PMID: 38100739
PMC: 10723639.
DOI: 10.1212/NXI.0000000000200185.
Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment.
Delgado S, Faissner S, Linker R, Rammohan K
J Neurol. 2023; 271(4):1515-1535.
PMID: 37906325
PMC: 10973056.
DOI: 10.1007/s00415-023-12007-3.
Proteomic interrogation of the meninges reveals the molecular identities of structural components and regional distinctions along the CNS axis.
Santorella E, Balsbaugh J, Ge S, Saboori P, Baker D, Pachter J
Fluids Barriers CNS. 2023; 20(1):74.
PMID: 37858244
PMC: 10588166.
DOI: 10.1186/s12987-023-00473-w.
[Recent Progress of Tertiary Lymphoid Structure in Prognosis and Immunotherapy of Non-small Cell Lung Cancer].
Liu Y, Xiong L, Cai R, Chen Y, Ye J, Shen B
Zhongguo Fei Ai Za Zhi. 2023; 26(8):615-620.
PMID: 37752541
PMC: 10558765.
DOI: 10.3779/j.issn.1009-3419.2023.101.23.
The CXCL13 Index as a Predictive Biomarker for Activity in Clinically Isolated Syndrome.
Pike S, Gilli F, Pachner A
Int J Mol Sci. 2023; 24(13).
PMID: 37446228
PMC: 10341709.
DOI: 10.3390/ijms241311050.
Emerging imaging and liquid biomarkers in multiple sclerosis.
Gill A, Schorr E, Gadani S, Calabresi P
Eur J Immunol. 2023; 53(8):e2250228.
PMID: 37194443
PMC: 10524168.
DOI: 10.1002/eji.202250228.
Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic.
De Seze J, Maillart E, Gueguen A, Laplaud D, Michel L, Thouvenot E
Front Immunol. 2023; 14:1004795.
PMID: 37033984
PMC: 10076836.
DOI: 10.3389/fimmu.2023.1004795.
The presence of cerebellar B cell aggregates is associated with a specific chemokine profile in the cerebrospinal fluid in a mouse model of multiple sclerosis.
Schropp V, Chunder R, Dietel B, Tacke S, Kuerten S
J Neuroinflammation. 2023; 20(1):18.
PMID: 36717913
PMC: 9885581.
DOI: 10.1186/s12974-023-02695-z.
Current Perspectives: Evidence to Date on BTK Inhibitors in the Management of Multiple Sclerosis.
Carnero Contentti E, Correale J
Drug Des Devel Ther. 2022; 16:3473-3490.
PMID: 36238195
PMC: 9553159.
DOI: 10.2147/DDDT.S348129.
The Brave New World of Early Treatment of Multiple Sclerosis: Using the Molecular Biomarkers CXCL13 and Neurofilament Light to Optimize Immunotherapy.
Pachner A
Biomedicines. 2022; 10(9).
PMID: 36140203
PMC: 9495360.
DOI: 10.3390/biomedicines10092099.
Innate Lymphoid Cells - Neglected Players in Multiple Sclerosis.
Sadeghi Hassanabadi N, Broux B, Marinovic S, Gotthardt D
Front Immunol. 2022; 13:909275.
PMID: 35784374
PMC: 9247827.
DOI: 10.3389/fimmu.2022.909275.